BCAB
Bioatla IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$6.62M
P/E Ratio
—
EPS
$-38.93
Beta
0.75
52W High
$71.50
52W Low
$3.12
50-Day MA
$3.89
200-Day MA
$18.00
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Bioatla Inc
BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapies for the treatment of various cancers. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $2.00M |
| Gross Profit (TTM) | $-32.90M |
| EBITDA | $-49.59M |
| Operating Margin | -2495.00% |
| Return on Equity | -814.00% |
| Return on Assets | -133.10% |
| Revenue/Share (TTM) | $1.59 |
| Book Value | $-22.48 |
| Price-to-Book | 2.68 |
| Price-to-Sales (TTM) | 3.31 |
| EV/Revenue | 5.6 |
| EV/EBITDA | 0.30 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 31.60% |
| Shares Outstanding | $1.66M |
| Float | $1.37M |
| % Insiders | 5.46% |
| % Institutions | 22.50% |
Historical Volatility
HV 10-Day
115.85%
HV 20-Day
93.90%
HV 30-Day
87.76%
HV 60-Day
90.88%
HV Rank
—
Volatility is currently expanding
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BCAB and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 7/18/2026